Evidence map›Paper›PMID 36225208›Full record

ArticleFrontiers in endocrinology2022

Daily requirement of softgel thyroxine is independent from gastric juice pH.

Camilla Virili, Silvia Capriello, Ilaria Stramazzo, Nunzia Brusca, Maria Giulia Santaguida, Lucilla Gargano, Maria Flavia Bagaglini, Giovanni Bruno, Carola Severi, Marco Centanni

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Camilla ViriliDepartment of Medico-surgical Sciences and Biotechnologies, ''Sapienza'' University of Rome, Latina, Italy.
Silvia CaprielloDepartment of Medico-surgical Sciences and Biotechnologies, ''Sapienza'' University of Rome, Latina, Italy.
Ilaria StramazzoDepartment of Medico-surgical Sciences and Biotechnologies, ''Sapienza'' University of Rome, Latina, Italy.
Nunzia BruscaEndocrine Unit, Azienda Unità Sanitaria Locale (AUSL) Latina, Latina, Italy.
Maria Giulia SantaguidaEndocrine Unit, Azienda Unità Sanitaria Locale (AUSL) Latina, Latina, Italy.
Lucilla GarganoEndocrine Unit, Azienda Unità Sanitaria Locale (AUSL) Latina, Latina, Italy.
Maria Flavia BagagliniDepartment of Medico-surgical Sciences and Biotechnologies, ''Sapienza'' University of Rome, Latina, Italy.
Giovanni BrunoDepartment of Translational and Precision Medicine, Gastroenterology Unit, ''Sapienza'' University of Rome, Rome, Italy.
Carola SeveriDepartment of Translational and Precision Medicine, Gastroenterology Unit, ''Sapienza'' University of Rome, Rome, Italy.
Marco CentanniDepartment of Medico-surgical Sciences and Biotechnologies, ''Sapienza'' University of Rome, Latina, Italy.
Sapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Softgel levothyroxine (LT4) preparation showed a better Methods: Twenty-eight hypothyroid patients (24F/4M; median age=50 treated with tablet LT4 (median dose= 1.65 µg/kg/day) and with stable thyroid stimulating hormone (TSH) values on target (<0.8-2.5> mU/l) have been shifted to softgel LT4 preparation. The dose of softgel LT4 has been titrated to obtain a similar individual serum TSH value. All subjects followed a specific treatment schedule, taking LT4 in fasting condition and then abstaining from eating or drinking for at least 1 hour. Owing to the presence of long-lasting dyspepsia or of already known gastric disorders, all patients underwent endoscopy, upon informed consent. Gastric juice has been collected during endoscopy to measure gastric pH. Then we plotted the dose of LT4 with the gastric pH obtained Results: Upon the switch tablet/softgel preparation, the therapeutic LT4 dose was very slightly reduced (-6%) in the whole sample. However, the individual variations revealed the existence of two populations, one without any dose reduction (A) and the other showing a dose reduction >20% (B). Upon matching with the actual gastric pH, patients with normal pH (A: n=17; 14F/3M, median 1.52) no showed a lower softgel LT4 requirement. Instead, among patients with reduced gastric acid production (B: n=11; 10F/1M, median pH 5.02) the vast majority (10/11; 91%, p<0.0001) benefited from a lower dose of softgel LT4 (median = -23%, p<0.0001). Interestingly, the dose of LT4 in tablet correlated with pH value (Spearman's ρ =0.6409; p = 0.0002) while softgel dose was independent from gastric juice pH (Spearman's ρ =1.952; p = 0.3194). Conclusions: These findings provide evidence that softgel LT4 preparation is independent from the actual gastric pH in humans and may represent a significant therapeutic option in patients with increased LT4 requirement, owed to disorders impairing the gastric acidic output.

Indexed as

ThyrotropinThyroxineGastric JuiceHumansHydrogen-Ion ConcentrationMiddle AgedTabletsTabletsThyrotropinThyroxineatrophic gastritisgastric juice pHHypothyroidismlevothyroxine malabsorptionlevothyroxine softgel

Identifiers

PMID36225208
PMCPMC9549358
OpenAlexW4297237263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.